» Articles » PMID: 39056721

Retrospective Single-Center Case Study of Clinical Variables and the Degree of Actinic Elastosis Associated with Rare Skin Cancers

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2024 Jul 26
PMID 39056721
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Rare skin cancers include epithelial, neuroendocrine, and hematopoietic neoplasias as well as cutaneous sarcomas. Ultraviolet (UV) radiation and sunburns are important drivers for the incidence of certain cutaneous sarcomas; however, the pathogenetic role of UV light is less clear in rare skin cancers compared to keratinocyte cancer and melanoma. In this study, we compared the degree of actinic elastosis (AE) as a surrogate for lifetime UV exposure among selected rare skin cancers (atypical fibroxanthoma [AFX], pleomorphic dermal sarcoma [PDS], dermatofibrosarcoma protuberans [DFSP], Kaposi sarcoma [KS], Merkel cell carcinoma [MCC], and leiomyosarcoma [LMS]) while taking into account relevant clinical variables (age, sex, and body site). (2) Methods: We newly established a semi-quantitative score for the degree of AE ranging from 0 = none to 3 = total loss of elastic fibers (basophilic degeneration) and multiplied it by the perilesional vertical extent (depth), measured histometrically (tumor-associated elastosis grade (TEG)). We matched the TEG of = 210 rare skin cancers from 210 patients with their clinical variables. (3) Results: TEG values were correlated with age and whether tumors arose on UV-exposed body sites. TEG values were significantly higher in AFX and PDS cases compared to all other analyzed rare skin cancer types. As expected, TEG values were low in DFSP and KS, while MCC cases exhibited intermediate TEG values. (4) Conclusions: High cumulative UV exposure is more strongly associated with AFX/PDS and MCC than with other rare skin cancers. These important results expand the available data associated with rare skin cancers while also offering insight into the value of differentiating among these tumor types based on their relationship with sun exposure, potentially informing preventative, diagnostic and/or therapeutic approaches.

References
1.
Simoes M, Sousa J, Pais A . Skin cancer and new treatment perspectives: a review. Cancer Lett. 2014; 357(1):8-42. DOI: 10.1016/j.canlet.2014.11.001. View

2.
Anderson H, Joseph A . A pilot feasibility study of a rare skin tumor database. Dermatol Surg. 2007; 33(6):693-6. DOI: 10.1111/j.1524-4725.2007.33145.x. View

3.
Schadendorf D, Lebbe C, Zur Hausen A, Avril M, Hariharan S, Bharmal M . Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. Eur J Cancer. 2016; 71:53-69. DOI: 10.1016/j.ejca.2016.10.022. View

4.
Agelli M, Clegg L . Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol. 2003; 49(5):832-41. DOI: 10.1016/s0190-9622(03)02108-x. View

5.
Ak M, Kahraman A, Arnold F, Turko P, Levesque M, Zoche M . Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden. Genes (Basel). 2021; 12(7). PMC: 8303615. DOI: 10.3390/genes12070974. View